| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3852646 | American Journal of Kidney Diseases | 2007 | 10 Pages |
Abstract
Simvastatin therapy appears to be effective and safe for the secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal dysfunction.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Michel MD, Thomas MS, John MD, Terje R. MD, JoAnn MD,